Atara Biotherapeutics, Inc. (ATRA) Form 424B5 — May 12, 2026
Atara Biotherapeutics, Inc. has updated its prospectus supplement to reflect that it may offer and sell shares of common stock with an aggregate offering price of $79,269,007. This update is consistent with the Staff Interpretation published by the Securities and Exchange Commission, which allows the company to continue offering and selling the full amount of securities covered by the prospectus supplement, even if it no longer meets the $75 million public float requirement. The common stock of Atara Biotherapeutics, Inc.
Key figures
- Gross Proceeds
- 79,269,007
- Aggregate offering price remaining
- 79,269,007
Price after filing
Close on the filing date to close N calendar days later (from $9.81). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.